Anticonvulsant and monoamine oxidase inhibitory properties of newer chlorostrylquinazolones.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology; D007735:Kynuramine / Q000494:pharmacology; D008297:Male; D008996:Monoamine Oxidase Inhibitors; D010433:Pentylenetetrazole / Q000494:pharmacology; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats
D000927:Anticonvulsants; D008996:Monoamine Oxidase Inhibitors; D011799:Quinazolines; D007735:Kynuramine; D010433:Pentylenetetrazole